The Center for Molecular and Behavioral Neuroscience (CMBN) of Universidad Central del Caribe (UCC) is applying for support for a Specialized Neuroscience Research Program. The proposed program consists of three interrelated research projects and a core facility. A series of additional activities will contribute to the scientific development of investigators, faculty, and students. In the process, we expect to elevate the quality of neuroscience research at the UCC to the level of national competitiveness. This program is a collaborative effort between UCC scientists and colleagues from four other universities. They share common interests and complement each other in knowledge and available methodology. The projects and activities are structured in order to benefit all parties involved. Project l addresses the neuroprotective role o nicotine and cembranoids, and will be conducted by Dr. Pedro Ferchmin from UCC (behavior and electrophysiology) and Dr. Jean de Vellis from University of California&Los Angeles (second messenger pathways). Project 2 will characterize the cembranoid and RNA binding sites on the nicotinic acetylcholine receptor, continuing a productive collaboration between Drs. Richard Hann and Vesna Eterovic from UCC, (receptor structure, ligand binding studies) and Dr. George Hess from Cornell University (electrophysiology using rapid kinetic technique and SELEX methodology). Project 3 will study the noradrenergic modulation of cocaine sensitization, with particular emphasis on RNAs that displace cocaine from the dopamine transporter. This project will integrate the expertise o Dr. Carlos Jimenez-Rivera (UCC, electrophysiology), Dr. Jose' Ortiz (Univ. of Puerto Rico-Medical Sciences Campus, neuropharmacology) and Dr. Hess. Finally, a 'Natural Products Core' directed by Dr. Rodriguez at the Univ. of Puerto Rico Rio Piedra5 will supply the cembranoids and synthetic derivatives needed for the work proposed. The proposed work is relevant to the important phenomena of neurodegeneration and neuropr0tection, with possible applications to stroke therapy. By clarifying some of the fundamental neural processes involved in sen5itization to psycho stimulants, it may also provide novel therapeutic strategies for the abuse of these substances. Finally, the studies on cholinergic receptors have possible applications to mya5thenia gravis and neurodegenerative diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54NS039408-03
Application #
6394276
Study Section
Special Emphasis Panel (ZNS1-SRB-L (01))
Program Officer
Jett, David A
Project Start
1999-09-30
Project End
2004-08-31
Budget Start
2001-09-01
Budget End
2002-08-31
Support Year
3
Fiscal Year
2001
Total Cost
$1,285,266
Indirect Cost
Name
Universidad Central Del Caribe
Department
Biochemistry
Type
Schools of Medicine
DUNS #
City
Bayamon
State
PR
Country
United States
Zip Code
00960
Budworth, Helen; Harris, Faye R; Williams, Paul et al. (2015) Suppression of Somatic Expansion Delays the Onset of Pathophysiology in a Mouse Model of Huntington's Disease. PLoS Genet 11:e1005267
Martins, Antonio H; Hu, Jing; Xu, Zhenfeng et al. (2015) Neuroprotective activity of (1S,2E,4R,6R,-7E,11E)-2,7,11-cembratriene-4,6-diol (4R) in vitro and in vivo in rodent models of brain ischemia. Neuroscience 291:250-259
Bykhovskaia, Maria; Jagota, Anand; Gonzalez, Agustin et al. (2013) Interaction of the complexin accessory helix with the C-terminus of the SNARE complex: molecular-dynamics model of the fusion clamp. Biophys J 105:679-90
Ferchmin, P A; Pérez, Dinely; Castro Alvarez, William et al. (2013) ?-Aminobutyric acid type A receptor inhibition triggers a nicotinic neuroprotective mechanism. J Neurosci Res 91:416-25
Torres-Rivera, W; Pérez, D; Park, K-Y et al. (2013) Kinin-B2 receptor exerted neuroprotection after diisopropylfluorophosphate-induced neuronal damage. Neuroscience 247:273-9
Eterovi?, Vesna A; Del Valle-Rodriguez, Angelie; Pérez, Dinely et al. (2013) Protective activity of (1S,2E,4R,6R,7E,11E)-2,7,11-cembratriene-4,6-diol analogues against diisopropylfluorophosphate neurotoxicity: preliminary structure-activity relationship and pharmacophore modeling. Bioorg Med Chem 21:4678-86
Maldonado, Carolina; Alicea, Daniel; Gonzalez, Maryvi et al. (2013) Adar is essential for optimal presynaptic function. Mol Cell Neurosci 52:173-80
Rodriguez-Mercado, Rafael; Ford, Gregory D; Xu, Zhenfeng et al. (2012) Acute neuronal injury and blood genomic profiles in a nonhuman primate model for ischemic stroke. Comp Med 62:427-38
Martins, Antonio H; Alves, Janaina M; Perez, Dinely et al. (2012) Kinin-B2 receptor mediated neuroprotection after NMDA excitotoxicity is reversed in the presence of kinin-B1 receptor agonists. PLoS One 7:e30755
Long, Rong; Hui, Chung-Yuen; Jagota, Anand et al. (2012) Adhesion energy can regulate vesicle fusion and stabilize partially fused states. J R Soc Interface 9:1555-67

Showing the most recent 10 out of 54 publications